Lucid Diagnostics (LUCD) CMO reports 650K restricted shares and 100K options

Lucid Diagnostics Chief Medical Officer, Victoria Lee Tou-ho, has filed an amended Form 3, disclosing her equity holdings. The report details 650,000 restricted shares of Common Stock with varying vesting dates through May 2029, dependent on service requirements. Additionally, she holds an employee stock option for 100,000 shares with an exercise price of $1.25, expiring in 2034.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin